α-Synuclein impairs macroautophagy: implications for Parkinson’s disease

Ashley R. Winslow(University of Cambridge), Chien‐Wen Chen(University of Cambridge), Silvia Corrochano(Mary Lyon Centre at MRC Harwell), Abraham Acevedo‐Arozena(Mary Lyon Centre at MRC Harwell), David E. Gordon(University of Cambridge), Andrew A. Peden(University of Cambridge), Maike Lichtenberg(University of Cambridge), Fiona M. Menzies(University of Cambridge), Brinda Ravikumar(University of Cambridge), Sara Imarisio(University of Cambridge), Steve D. M. Brown(Mary Lyon Centre at MRC Harwell), Cahir J. O’Kane(University of Cambridge), David C. Rubinsztein(University of Cambridge)
The Journal of Cell Biology
September 20, 2010
Cited by 820Open Access
Full Text

Abstract

Parkinson's disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.


Related Papers

No related papers found

Powered by citation graph analysis